|Articles|January 13, 2022
Clinical Pearl of the Day: Germ Cell Tumors
Author(s)Saro Arakelians, PharmD
Germ cell tumors that occur in places other than the testicles and ovaries are very rare.
Advertisement
Clinical Pearl of the Day: Germ Cell Tumors
Germ cell tumors are growths of cells that form from reproductive cells.
Insight:
- Germ cell tumors may or may not be cancerous. Most germ cell tumors occur in the testicles or the ovaries.
- Some germ cell tumors occur in other areas of the body, such as the abdomen, brain and chest, though it's not clear why.
- Germ cell tumors that occur in places other than the testicles and ovaries (extragonadal germ cell tumors) are very rare.
- Treatment options for germ cell tumors may include surgery to remove the tumor, chemotherapy with drugs that kill cancer cells, and radiation therapy with powerful energy beams.
- The drugs that are commonly used for treating germ cell tumors include bleomycin (available as a generic drug), cisplatin (available as a generic drug), etoposide (Etopophos), and ifosfamide (Ifex).
- Support: Physical and emotional support is another treatment option that may be needed for these patients.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
2
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5